SS-31
Elamipretide · Bendavia · MTP-131
Mitochondrial-targeted tetrapeptide (elamipretide).
A cardiolipin-binding tetrapeptide that concentrates in mitochondria. Investigated for primary mitochondrial myopathy, Barth syndrome, and age-related mitochondrial decline.
Usual range
4–40 mg
Schedule
Once daily
Half-life
Hours
How it is used
Mitochondrial-targeted tetrapeptide (elamipretide).
Subcutaneous
Morning.
Trial regimens were weeks to months. Anecdotal use 4–8 weeks.
How to mix this vial
Typical vial 50 mg · 5 mL BAC
Research vials vary (10–50 mg). Example: 50 mg + 5 mL → 10 mg/mL. 5 mg = 50 units.
Fridge. Protect from light.
Side effects
- Injection-site reactions (common)
- Eosinophilia in some trials
- Headache
Who should skip this
- Known hypersensitivity
- Pregnancy
Nutrition note
Mediterranean-style fats (olive oil, fish) support membranes more than any powder.
Stacks
Often paired with
Elamipretide remains investigational in most indications.
Peptipedia is an educational calculator, not medical advice. Many catalog entries are unapproved for human use. Approved molecules have labels that outrank this app. Do not use this to self-prescribe. Consult a licensed clinician. Not for anyone under 18, pregnant, or being treated for cancer.